Shares of GSK PLC GSK inched down 0.55% to £15.28 Monday, on what proved to be an all-around favorable trading session for ...

New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the treatment of ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. GSK’s ex-head of vaccines says ...

Assembly Biosciences reported interim results from its Phase 1a study of ABI-5366, a long-acting HSV inhibitor for recurrent ...

Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

TIME convenes first-ever TIME100 Climate Leadership Forum, featuring impactful conversations driving change for a more ...

New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the <a target=_blank href=https ...

Discover the potential of nature-based real assets for institutional investors. Learn how HSBC and Pollination's Climate Asset Management is leading the way.

We recently published a list of 10 Worst Small Cap AI Stocks To Buy According to Short Sellers. In this article, we are going ...